AngioDynamics Historical Financial Ratios
| ANGO Stock | USD 10.18 0.10 0.99% |
AngioDynamics is presently reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 1.17 or Days Sales Outstanding of 68.02 will help investors to properly organize and evaluate AngioDynamics financial condition quickly.
AngioDynamics |
About AngioDynamics Financial Ratios Analysis
AngioDynamicsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate AngioDynamics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on AngioDynamics financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across AngioDynamics history.
AngioDynamics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing AngioDynamics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on AngioDynamics sales, a figure that is much harder to manipulate than other AngioDynamics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most ratios from AngioDynamics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into AngioDynamics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.At this time, AngioDynamics' Income Quality is very stable compared to the past year. As of the 25th of March 2025, Intangibles To Total Assets is likely to grow to 0.38, while Price To Sales Ratio is likely to drop 0.91.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 56.92 | 52.38 | 60.23 | 68.02 | PTB Ratio | 0.99 | 1.23 | 1.11 | 1.17 |
AngioDynamics fundamentals Correlations
Click cells to compare fundamentals
AngioDynamics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AngioDynamics fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 3.09 | 2.42 | 1.1 | 0.83 | 0.96 | 0.91 | |
| Ptb Ratio | 2.05 | 1.8 | 0.99 | 1.23 | 1.11 | 1.17 | |
| Days Sales Outstanding | 44.41 | 60.37 | 56.92 | 52.38 | 60.23 | 68.02 | |
| Book Value Per Share | 11.46 | 10.88 | 9.58 | 5.12 | 4.6 | 4.37 | |
| Free Cash Flow Yield | (0.0562) | 0.0115 | (0.015) | (0.0114) | (0.13) | (0.15) | |
| Operating Cash Flow Per Share | 0.63 | (0.18) | 0.001976 | (0.7) | (0.81) | (0.77) | |
| Stock Based Compensation To Revenue | 0.0296 | 0.0338 | 0.0329 | 0.0346 | 0.0312 | 0.019 | |
| Capex To Depreciation | 0.53 | 0.15 | 0.14 | 0.21 | 0.24 | 0.23 | |
| Pb Ratio | 2.05 | 1.8 | 0.99 | 1.23 | 1.11 | 1.17 | |
| Ev To Sales | 3.0 | 2.44 | 1.12 | 0.6 | 0.69 | 0.66 | |
| Free Cash Flow Per Share | 0.27 | (0.29) | (0.11) | (0.84) | (0.97) | (0.92) | |
| Inventory Turnover | 2.76 | 2.93 | 2.97 | 2.46 | 2.22 | 2.14 | |
| Net Income Per Share | (0.82) | (0.68) | (1.33) | (4.59) | (5.28) | (5.01) | |
| Days Of Inventory On Hand | 132.2 | 124.65 | 122.75 | 148.27 | 170.51 | 158.42 | |
| Payables Turnover | 6.84 | 5.37 | 4.07 | 3.95 | 4.55 | 7.62 | |
| Research And Ddevelopement To Revenue | 0.13 | 0.0972 | 0.0882 | 0.1 | 0.0933 | 0.0703 | |
| Capex To Revenue | 0.0471 | 0.0136 | 0.0128 | 0.019 | 0.0218 | 0.0398 | |
| Cash Per Share | 1.26 | 0.74 | 1.13 | 1.89 | 2.18 | 2.38 | |
| Pocfratio | 37.38 | (106.44) | 4.8K | (9.0) | (8.1) | (7.7) | |
| Interest Coverage | (15.62) | (17.27) | (27.63) | (7.12) | (8.19) | (7.78) | |
| Capex To Operating Cash Flow | (0.52) | 0.57 | (0.6) | 55.79 | (0.2) | (0.18) | |
| Pfcf Ratio | 86.75 | (66.64) | (87.39) | (7.47) | (8.59) | (8.16) | |
| Days Payables Outstanding | 53.38 | 68.03 | 89.74 | 92.34 | 83.11 | 46.23 | |
| Income Quality | 0.0878 | (0.76) | 0.27 | (0.001487) | 0.15 | 0.18 | |
| Roe | (0.0718) | (0.0625) | (0.14) | (0.9) | (0.81) | (0.77) | |
| Ev To Operating Cash Flow | 36.21 | (107.13) | 4.9K | (6.51) | (5.86) | (5.57) | |
| Pe Ratio | (28.55) | (28.85) | (7.12) | (1.38) | (1.58) | (1.5) | |
| Return On Tangible Assets | (0.84) | (0.17) | (0.13) | (0.2) | (0.77) | (0.88) | |
| Ev To Free Cash Flow | 84.04 | (67.07) | (88.6) | (5.41) | (6.22) | (5.91) | |
| Earnings Yield | (0.035) | (0.0347) | (0.14) | (0.73) | (0.84) | (0.79) | |
| Intangibles To Total Assets | 0.66 | 0.64 | 0.51 | 0.24 | 0.22 | 0.38 | |
| Net Debt To E B I T D A | 3.16 | 0.45 | 0.43 | 4.91 | 4.42 | 4.64 | |
| Current Ratio | 2.45 | 1.93 | 1.95 | 2.12 | 2.44 | 4.28 | |
| Tangible Book Value Per Share | 1.51 | 1.8 | 1.82 | 2.73 | 3.19 | 3.67 | |
| Receivables Turnover | 8.22 | 6.05 | 6.41 | 6.97 | 6.27 | 5.26 | |
| Shareholders Equity Per Share | 11.46 | 10.88 | 9.58 | 5.12 | 4.6 | 4.37 | |
| Debt To Equity | 0.0455 | 0.0796 | 0.13 | 0.0288 | 0.0259 | 0.0272 | |
| Capex Per Share | 0.2 | 0.36 | 0.11 | 0.14 | 0.17 | 0.29 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.59) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets | Return On Equity |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.